Hypothalamus-specific polypeptides

Details Hypothalamus-specific polypeptides Hypothalamus-specific polypeptides

1999-02-02

2003-10-21

Falk, Anne-Marie (Department: 1632)

Chemistry: molecular biology and microbiology

Animal cell, per se ; composition thereof; process of...

C435S320100, C536S023100, C536S023500

Reexamination Certificate

active

06635479

ABSTRACT:

FIELD OF THE INVENTION
This invention relates to the identification, isolation, sequencing, use, and expression of hypothalamus-specific proteins and fragments thereof.
BACKGROUND OF THE INVENTION
The hypothalamus, a phylogenetically ancient region of the mammalian brain, is responsible for the integration of the central nervous system and the endocrine system and is particularly related to the physiological response to stress. In contrast to laminar cortical structures such as the cerebellum and hippocampus whose final functions rely on innervation from the thalamus and brain stem, the hypothalamus is organized as a collection of distinct, autonomously active nuclei with discrete functions. Ablation and electrical stimulation studies and medical malfunctions have implicated several of these nuclei as central regulatory centers for major autonomic and endocrine homeostatic systems mediating processes such as reproduction, lactation, fluid balance, metabolism, and aspects of behaviors, such as circadian rhythmicity, basic emotions, feeding and drinking, mating activities, and responses to stress, as well as normal development of the immune system (Shepherd, G. M.,
Neurobiology
, 3rd ed. Oxford University Press, New York, 1994). Distinct hormones and releasing factors have been associated with some of these nuclei but, at best, the organizations and molecular operations of these structures are only partially understood.
A substantial portion of a mammal's genetic endowment is dedicated to the function of its central nervous system, as evidenced by the substantial number of mRNAs selectively expressed in the brain (Sutcliffe, J. G.,
Ann. Rev. Neurosci
. 11:157-198, 1988). Many of these have been observed to be selectively associated with distinct neural subsets. Existing knowledge of the expression of specific hypothalamic hormones and releasing factors suggests that ensembles of mRNAs selectively associated with discrete hypothalamic nuclei may encode proteins singularly associated with the unique functions of those nuclei.
SUMMARY OF THE INVENTION
The present invention provides peptides and polypeptides found in the hypothalamus region of the mammalian brain. Preferably, the peptides and polypeptides are enriched in the hypothalamus relative to other regions of the brain. More preferably the peptides and polypeptides are specific to the hypothalamus. One embodiment is the rat polypeptide hypocretin also referred to as, H35 protein or clone 35 protein (SEQ ID NO:1) and polypeptide analogs thereof having at least one conservative amino acid substitution. Another embodiment is the mouse hypocretin polypeptide (SEQ ID NO:2) and polypeptide analogs thereof having at least one conservative amino acid substitution.
The present invention also provides polynucleotides encoding peptides and polypeptides found in the hypothalamus region of the brain. Preferably, the polynucleotides encoding peptides and polypeptides are enriched in the hypothalamus relative to other regions of the brain. More preferably the polynucleotides encoding peptides and polypeptides are specific to the hypothalamus. One embodiment is a polynucleotide chosen from the group consisting of the polynucleotide of SEQ ID NO:3, a polynucleotide having at least about 95% of its nucleotide sequence identical to the polynucleotide of SEQ ID NO:3, and polynucleotides hybridizing to the polynucleotide of SEQ ID NO: 3. Another embodiment is a polynucleotide chosen from the group consisting of the polynucleotide of SEQ ID NO:4, a polynucleotide having at least about 95% of its nucleotide sequence identical to the polynucleotide of SEQ ID NO:4, and polynucleotides hybridizing to the polynucleotide of SEQ ID NO: 4.
Also provided are vectors for the expression of the novel polynucleotides operably linked to control sequences capable of directing the production of the novel polypeptides in suitable host cells.
In other aspects this invention provides pharmaceutical compositions of the polynucleotides, polypeptides and peptides, antibodies to the peptides and polypeptides as well as compositions thereof. This invention also provides assay methods and kits for practicing the methods, and methods for using the polynucleotides, peptides and polypeptides for diagnostic and therapeutic purposes.


REFERENCES:
patent: 5969123 (1999-10-01), Holtzman
Lee et al., Comparative expressed-sequence-tag analysis of differential gene expression profiles in PC-12 cells before and after nerve growth factor treatment. PNAS (USA) 92:8303-8307 (1995).
Cho et al., Characterization of a rat cDNA clone encoding calcium/calmodulin-dependent protein kinase I. Biochimica et Biophysica Acta 1224(1):156-160 (1994).
Charnock-Jones et al., Extension of incomplete cDNAs (ESTs) by biotin/strepavidin-mediated walking using the polymerase chain reaction. J. Biotechnology 35(2-3):205-215 (1994).
Fehmann et al., Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide. Endocrine Reviews 16(3):390-410 (1995).
Hudson T. Human STS WT-10041. GENBANK Accession No. G11664. Oct. 19, 1995.

Affiliated with

Also associated with

Rating

Hypothalamus-specific polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hypothalamus-specific polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hypothalamus-specific polypeptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3127211